Regarding the new coronavirus vaccine manufactured by American pharmaceutical company Moderna, the target age for the third and subsequent booster vaccinations will be lowered from 18 years old and over to 12 years old and over.
Moderna's new coronavirus vaccine has a target age of 18 years or older for the third and subsequent boosters, and Moderna has applied for a reduction in the target age.
Then, on the 8th, a subcommittee of experts from the Ministry of Health, Labor and Welfare was held, and it was agreed to lower the target age to 12 years or older, saying that the efficacy and safety were confirmed as a result of clinical trials by pharmaceutical companies.
Vaccines for Omicron strains such as BA.5, which are currently inoculated, vaccines for BA.1, and conventional vaccines are also eligible.
Regarding the effect, in a clinical trial conducted from the age of 12 to 17 with a conventional vaccine, the value of "neutralizing antibody" that suppresses the action of the virus produced in the body was a clinical trial conducted from the age of 18 to 25. The Ministry of Health, Labor and Welfare says that the effectiveness can be expected because it increased to the same extent as the result of
In addition, there are no serious concerns regarding safety.
It is expected that the reduction of the target age for Moderna's vaccine booster will start operation within this month.